Last Updated on eMC 12-01-2018 View medicine  | Bayer plc Contact details

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC.  For each version, we show the dates it was published on the eMC and the reasons for change.

Reasons for adding or updating:

  • Change to section 6 - marketing authorisation holder

Reasons for adding or updating:

  • Change to section 6 - manufacturer

Reasons for adding or updating:

  • Change to section 5 - how to store
  • Improved presentation of PIL

Reasons for adding or updating:

  • Change to section 2 - what you need to know - warnings and precautions
  • Change to section 2 - interactions with other medicines, food or drink
  • Change to section 3 - dose and frequency
  • Change to section 4 - possible side effects
  • Change to section 6 - date of revision

Reasons for adding or updating:

  • Change to manufacturer contact details

Reasons for adding or updating:

  • Change to side-effects
  • Change to drug interactions

Reasons for adding or updating:

  • Change to name of manufacturer

Reasons for adding or updating:

  • Change to date of revision

Reasons for adding or updating:

  • Change of manufacturer

Reasons for adding or updating:

  • Update to PIL

Reasons for adding or updating:

  • No reasons supplied